Evidence map›Paper›PMID 34495350›Full record

ArticleEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2022

Detectability of 18F-choline PET/MR in primary hyperparathyroidism.

Mine Araz, Demet Nak, Çiğdem Soydal, Elif Peker, İlhan Erden, N Özlem Küçük

Abstract read
PubMed Publisher
In one paragraph

Article in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. MR Pulse Sequences for Parathyroid Adenoma Imaging Using [Nuclear medicine and molecular imaging · 2026
    Article
  2. [European journal of nuclear medicine and molecular imaging · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Diagnostics (Basel, Switzerland) · 2021
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Mine ArazNuclear Medicine Department, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey. minesoylu@yahoo.com.ORCID http://orcid.org/0000-0001-6467-618X
Demet NakNuclear Medicine Department, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey.
Çiğdem SoydalNuclear Medicine Department, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey.
Elif PekerRadiology Department, Ankara University Medical School, Ankara, Turkey.
İlhan ErdenRadiology Department, Ankara University Medical School, Ankara, Turkey.
N Özlem KüçükNuclear Medicine Department, Cebeci Hospital, Ankara University Medical Faculty, Ankara, Turkey.
Ankara University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeWe aimed to evaluate the power of 18F-fluorocholine (FCH) positron emission tomography/magnetic resonance (PET/MR) imaging in unlocalized primary hyperparathyroidism.

methodsThirty-four patients were included. In 17/34 patients, PET/MR was performed immediately after a negative 18F-FCH PET/CT. Sensitivity, specificity, positive and negative predictive values were calculated for MR only (blinded to PET data) and PET only (blinded to MR data) findings.

results18F-FCH PET/MR was positive in 26/34 (76%) patients. PET/MR was also positive in 12/17 (71%) patients with a negative PET/CT. Among 11/34 (32%) patients where 18F-FCH PET-only and MR-only results were discordant, MR was false positive in 7/11 patients (3/7 of the lesions were not 18F-FCH avid and in 4/7 of them PET and MRI pointed different locations. Postoperative histopathology revealed that 18F-FCH-positive ones were true positives). Sensitivity, specificity, PPV, NPV and accuracy of neck MR evaluated blinded to PET data were 80%, 50%, 70%, 64% and 68%, respectively, and all were calculated as 100% for PET/MR.

conclusion18F-FCH PET/MR is very effective in preoperative localization of parathyroid adenomas even if 18F-FCH PET/CT is negative. Neck MR alone is insufficient in detecting parathyroid adenomas but PET/MR combination helps in precise localisation.

Indexed as

Hyperparathyroidism, PrimaryParathyroid NeoplasmsCholineHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyPositron-Emission TomographyPositron Emission Tomography Computed TomographyCholinefluorocholinefluoromethylcholineCholineHyperparathyroidismMagnetic resonance imagingPositron emission tomographyRadionuclide imaging

Identifiers

PMID34495350
OpenAlexW3196877800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.